Related Experiment Video

Updated: Jul 7, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Mycoplasma fermentans glycolipid-antigen as a pathogen of rheumatoid arthritis

Yutaka Kawahito1, Sizuko Ichinose, Hajime Sano

  • 1Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-ku, Kawaramachi-Hirokoji Kamigyo-ku, Kyoto-shi, Kyoto 602-0841, Japan.

Biochemical and Biophysical Research Communications
|March 1, 2008
PubMed

Insights

Mycoplasma fermentans glycolipid-antigens (GGPL-III) were found in rheumatoid arthritis (RA) tissues, inducing inflammatory cytokines and fibroblast proliferation. This suggests GGPL-III as a potential target for RA immunotherapies.

Area of Science:

  • Immunology
  • Microbiology
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) pathogenesis remains incompletely understood, with Mycoplasma fermentans suspected as a causative agent.
  • Previous research identified glycolipid-antigens (GGPL-I and III) as major Mycoplasma fermentans antigens.

Purpose of the Study:

  • To investigate the presence and role of Mycoplasma fermentans GGPL-III antigens in rheumatoid arthritis pathogenesis.
  • To explore potential immunotherapeutic targets for RA based on GGPL-III.

Main Methods:

  • Monoclonal antibody detection of GGPL-III antigens in synovial tissues from RA, osteoarthritis (OA), and normal patients.
  • Immunoelectron microscopy to localize GGPL-III antigens within synovial tissues.
  • Assays measuring TNF-alpha and IL-6 production by peripheral blood mononuclear cells (PBMCs) and synovial fibroblast proliferation induced by GGPL-III.

Main Results:

  • GGPL-III antigens were detected in 38.1% of RA patient synovial tissues, but not in OA or normal tissues.
  • Immunoelectron microscopy localized GGPL-III antigens within the endoplasmic reticulum of synovial cells.
  • GGPL-III significantly stimulated the production of TNF-alpha and IL-6 from PBMCs and promoted synovial fibroblast proliferation.

Conclusions:

  • Mycoplasma fermentans GGPL-III is present in RA synovial tissues and can induce key inflammatory mediators and cellular responses implicated in RA pathogenesis.
  • GGPL-III represents a promising target for developing novel immunotherapeutic strategies for rheumatoid arthritis.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...